These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29675762)

  • 1. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
    Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.
    Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC
    Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
    Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
    Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
    O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
    J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adjuvant chemotherapy in stage II and III mucinous colon cancer.
    Fields AC; Lu P; Goldberg J; Irani J; Bleday R; Melnitchouk N
    J Surg Oncol; 2019 Dec; 120(7):1190-1200. PubMed ID: 31536150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer.
    Teufel A; Gerken M; Hartl J; Itzel T; Fichtner-Feigl S; Stroszczynski C; Schlitt HJ; Hofstädter F; Klinkhammer-Schalke M
    BMC Cancer; 2015 May; 15():419. PubMed ID: 25985893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
    Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
    Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study based on SEER database: not all high-risk factors are equal for stage II colon cancer.
    Li D; Jiang Z; Xiang L; Yang C; Long F; Liu W
    Transl Cancer Res; 2022 Apr; 11(4):689-698. PubMed ID: 35571652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.
    Margalit O; Mamtani R; Lawrence YR; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Clin Colorectal Cancer; 2019 Sep; 18(3):226-230.e2. PubMed ID: 31097386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.